ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer.

Sandra J Casak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.